我们对157例弥漫性甲状腺肿伴甲状腺机能亢进症(Graves’病)患者和32例正常人进行了血清抗DNA抗体结合活性试验,结果如下。一、对象和方法1.对象:157例Graves’病患者,临床表现与甲状腺功能(T_3、T_4、TSH等)测定均符合诊断,按治疗时间长短及复发与缓解分为3组。甲组37例为新诊断患者,均未行抗甲药物治疗;乙组53例,为治疗后症状及甲功仍未控制或复发者,均已 Serum anti-DNA antibody binding activity was tested in 157 patients with Graves’ disease and 32 normal controls. The results are as follows. First, the object and method 1. Subjects: 157 patients with Graves’ disease, clinical manifestations and thyroid function (T_3, T_4, TSH, etc.) were measured in line with the diagnosis, according to the length of treatment and recurrence and remission were divided into three groups. A group of 37 cases of newly diagnosed patients, were not anti-A drug treatment; B group 53 cases, after treatment of symptoms and thyroid function have not yet been controlled or relapse, have been